Exabis Library
Welcome to the e-CCO Library!
P033: Single-cell analysis of gut mucosal- and peripheral blood cells in ulcerative colitis patients undergoing vedolizumab treatment
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P033: The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P033: The efficacy of tonsil-derived mesenchymal stem cells conditioned medium in chronic colitis model
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P034 GB004, a novel gut-targeted prolyl hydroxylase inhibitor, induces HIF-1α target genes and is efficacious in mouse colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P034: A common IL2RA polymorphism alters natural killer cell immunophenotype and function in Crohn's disease, with implications for IL-2 based therapy
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P034: A dietary fibre intervention shapes the microbiome towards an anti-inflammatory tone
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P034: Altered microbiota and host-bacterial interactions during the spontaneous development of colitis in IL-10 knockout mice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P034: DISRUPTive liquid biopsies in Inflammatory Bowel Disease (DISRUPT-IBD): Release of exosomal and molecular tissue signals by transabdominal ultrasound?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P034: Human primary 2D culture as a tool to explore JAK1 pathway inhibition in the intestinal epithelium using siRNA technology
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P034: Immunoregulatory properties of human adipose–derived stem cells in inflammatory diseases: differences between Crohn´s disease and obesity
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P034: Validation of a novel xenograft mouse model for intestinal fistulas
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P035 NUDT15 variance increases DNA-incorporated thiopurine metabolites and lymphocyte apoptosis in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P035: An examination of resting state functional connectivity in patients with active Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P035: Anti-inflammatory Effect and Mechanism of Action of BMC333, a Rationally-Designed Live Bacterial Consortium Based on Microbiome Functional Genomic Analysis for Treating IBD
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P035: Lamina propria CD4+LAP+ Foxp3- regulatory cells are involved in limiting the disease extension in Ulcerative Colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P035: Pharmacological inhibition of the canonical WNT signalling pathway represents a potential novel therapy for fibrosis in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P035: Potential biomarkers for diagnosis through proteomics, in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P035: Serum markers predict outcome to ustekinumab in patients with refractory Crohn’s disease and provide insides in the mechanism of action
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P035: TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM